Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Elizaveta N. Mochalova"'
Autor:
Olga A. Kolesnikova, Elena N. Komedchikova, Svetlana D. Zvereva, Anastasiia S. Obozina, Olha V. Dorozh, Iurii Afanasev, Petr I. Nikitin, Elizaveta N. Mochalova, Maxim P. Nikitin, Victoria O. Shipunova
Publikováno v:
Heliyon, Vol 10, Iss 14, Pp e34211- (2024)
Cancer is unquestionably a global healthcare challenge, spurring the exporation of novel treatment approaches. In recent years, nanomaterials have garnered significant interest with the greatest hopes for targeted nanoformulations due to their cell-s
Externí odkaz:
https://doaj.org/article/527753f08b494f01a04e41c509c89af6
Autor:
Elizaveta N. Mochalova, Elena A. Egorova, Kristina S. Komarova, Victoria O. Shipunova, Nelli F. Khabibullina, Petr I. Nikitin, Maxim P. Nikitin
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 13, p 10623 (2023)
Recent developments in the field of nanomedicine have introduced a wide variety of nanomaterials that are capable of recognizing and killing tumor cells with increased specificity. A major limitation preventing the widespread introduction of nanomate
Externí odkaz:
https://doaj.org/article/d8a9dfeb4bb246d090077e1554746537
Autor:
Anastasiia S. Obozina, Elena N. Komedchikova, Olga A. Kolesnikova, Anna M. Iureva, Vera L. Kovalenko, Fedor A. Zavalko, Tatiana V. Rozhnikova, Ekaterina D. Tereshina, Elizaveta N. Mochalova, Victoria O. Shipunova
Publikováno v:
Pharmaceutics, Vol 15, Iss 1, p 231 (2023)
Targeted nanoparticles of different origins are considered as new-generation diagnostic and therapeutic tools. However, there are no targeted drug formulations within the composition of nanoparticles approved by the FDA for use in the clinic, which i
Externí odkaz:
https://doaj.org/article/3a598a427a1b4e2bb5344a7380ee2cb4
Autor:
Andrey S. Drozdov, Kristina S. Komarova, Elizaveta N. Mochalova, Elena N. Komedchikova, Victoria O. Shipunova, Maxim P. Nikitin
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 1, p 134 (2022)
Nanostructured materials and systems find various applications in biomedical fields. Hybrid organo–inorganic nanomaterials are intensively studied in a wide range of areas, from visualization to drug delivery or tissue engineering. One of the recen
Externí odkaz:
https://doaj.org/article/b942f7b26c294d0a89288c6eb6daca70
Autor:
Vera A. Bragina, Elena Khomyakova, Alexey V. Orlov, Sergey L. Znoyko, Elizaveta N. Mochalova, Liliia Paniushkina, Victoria O. Shender, Thalia Erbes, Evgeniy G. Evtushenko, Dmitry V. Bagrov, Victoria N. Lavrenova, Irina Nazarenko, Petr I. Nikitin
Publikováno v:
Nanomaterials, Vol 12, Iss 9, p 1579 (2022)
Extracellular vesicles (EVs) are promising agents for liquid biopsy—a non-invasive approach for the diagnosis of cancer and evaluation of therapy response. However, EV potential is limited by the lack of sufficiently sensitive, time-, and cost-effi
Externí odkaz:
https://doaj.org/article/25669832ab2a4e998ad7af22dfab4a88
Autor:
Afanasy V. Lunin, Anna A. Lizunova, Elizaveta N. Mochalova, Maria N. Yakovtseva, Vladimir R. Cherkasov, Maxim P. Nikitin, Eugene L. Kolychev
Publikováno v:
Molecules, Vol 25, Iss 8, p 1984 (2020)
The development of synthetic ways to fabricate nanosized materials with a well-defined shape, narrow-sized distribution, and high stability is of great importance to a rapidly developing area of nanotechnology. Here, we report an unusual reaction bet
Externí odkaz:
https://doaj.org/article/9f3487fb0b6548b2bc64f901dd9a0b53
Autor:
Nikitin, Elizaveta N. Mochalova, Elena A. Egorova, Kristina S. Komarova, Victoria O. Shipunova, Nelli F. Khabibullina, Petr I. Nikitin, Maxim P.
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 13; Pages: 10623
Recent developments in the field of nanomedicine have introduced a wide variety of nanomaterials that are capable of recognizing and killing tumor cells with increased specificity. A major limitation preventing the widespread introduction of nanomate
Autor:
Elizaveta N. Mochalova
Publikováno v:
Cell Death Discovery
Publikováno v:
Cell Death Discovery
Sponsorship: Publication of this supplement was sponsored by the Medical Research Council (MRC). All content was reviewed and approved by the European Cell Death Organization (ECDO) Committee, which held full responsibility for the abstract selection